These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21060027)

  • 1. Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma.
    Regelink JC; van Roessel CH; van Galen KP; Ossenkoppele GJ; Huijgens PC; Zweegman S
    J Clin Oncol; 2010 Dec; 28(35):e741-3; author reply e744-5. PubMed ID: 21060027
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
    Mehta J
    J Natl Cancer Inst; 2009 Oct; 101(20):1430-1; author reply 1431-3. PubMed ID: 19794130
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandem bone marrow transplantation in multiple myeloma.
    Chng WJ
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074003
    [No Abstract]   [Full Text] [Related]  

  • 5. Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.
    Beaven AW; Moore DT; Sharf A; Serody JS; Shea TC; Gabriel DA
    Cancer Invest; 2011 Mar; 29(3):214-9. PubMed ID: 21314330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.
    Kröger N; Einsele H; Derigs G; Wandt H; Krüll A; Zander A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):861-4. PubMed ID: 20139025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?
    Sucak G; Suyanı E; Özkurt ZN; Yeğin ZA; Aki Z; Yagci M
    Hematol Oncol; 2010 Dec; 28(4):180-4. PubMed ID: 20155734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.
    Lokhorst H; Einsele H; Vesole D; Bruno B; San Miguel J; Pérez-Simon JA; Kröger N; Moreau P; Gahrton G; Gasparetto C; Giralt S; Bensinger W;
    J Clin Oncol; 2010 Oct; 28(29):4521-30. PubMed ID: 20697091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
    Tricot G; Kern SE; Barlogie B
    J Natl Cancer Inst; 2009 Jul; 101(13):964-6; author reply 966-7. PubMed ID: 19535776
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future.
    Björkstrand B; Gahrton G
    Semin Hematol; 2007 Oct; 44(4):227-33. PubMed ID: 17961721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic stem cell transplantation in multiple myeloma].
    Vela-Ojeda J; Ruiz-Esparza MA
    Rev Invest Clin; 2005; 57(2):305-13. PubMed ID: 16524072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem bone marrow transplantation in multiple myeloma.
    Murashige N; Kishi Y
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15070801
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced.
    van Dorp S; Meijer E; van de Donk NW; Dekker AW; Nieuwenhuis K; Minnema MC; Petersen E; Schutgens R; Verdonck LF; Lokhorst HM
    Neth J Med; 2007 May; 65(5):178-84. PubMed ID: 17519513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem-cell transplantation in multiple myeloma.
    Gahrton G
    Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The allogeneic dilemma.
    Harousseau JL
    Bone Marrow Transplant; 2007 Dec; 40(12):1123-8. PubMed ID: 17680016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
    Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S
    Cancer; 2006 May; 106(10):2171-80. PubMed ID: 16598756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.